Stem Cell Transplantation Therapy for Retinal Degenerative Diseases

Area of Science:

• Ophthalmology and Regenerative Medicine

Background:

• Significant advancements in human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) research.
• Established basis for deriving retinal cells (RPE, photoreceptors, ganglion cells) for retinal degenerative diseases (RDD) transplantation therapy.
• Recent success of iPSC-derived retinal pigment epithelium (RPE) cells in treating age-related macular degeneration (AMD).

Purpose of the Study:

• To review research advances in stem cell transplantation for RDD.
• To propose challenges for improving clinical efficacy and safety of hESC/iPSC-derived retinal neural cells.

Main Methods:

• Review of stem cell transplantation research.
• Analysis of animal studies and clinical trials.
• Identification of challenges in cell differentiation and delivery.

Main Results:

• hESCs and iPSCs can be differentiated into various retinal cell types.
• iPSC-derived RPE cells have demonstrated efficacy in AMD patients.
• Challenges remain in clinical-grade cell differentiation and retinal delivery methods.

Conclusions:

• Stem cell transplantation holds significant potential for treating RDD.
• Further optimization of cell differentiation protocols and delivery techniques is crucial.
• Addressing challenges in efficacy and safety is key for successful clinical translation.